We are live on ! Find out more
LP

Longaeva Partners Portfolio holdings

AUM $2.7B
1-Year Est. Return 37.16%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+37.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$1.51B
Cap. Flow
+$1.75B
Cap. Flow %
64.98%
Top 10 Hldgs %
35.87%
Holding
269
New
150
Increased
33
Reduced
19
Closed
65

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$80.3M
2
BSX icon
Boston Scientific
BSX
+$76.6M
3
KEY icon
KeyCorp
KEY
+$62.3M
4
GS icon
Goldman Sachs
GS
+$60.3M
5
MMED
MiniMed Group Inc
MMED
+$52.4M

Top Sells

Rank Stock Value
1
CAI
Caris Life Sciences
CAI
+$40.7M
2
BDX icon
Becton Dickinson
BDX
+$25.5M
3
TPG icon
TPG
TPG
+$23.9M
4
NVO
Novo Nordisk
NVO
+$22.6M
5
EW icon
Edwards Lifesciences
EW
+$22.1M

Sector Composition

Rank Sector Weight
1 Financials 31.18%
2 Healthcare 16.78%
3 Technology 12.09%
4 Industrials 6.84%
5 Consumer Discretionary 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLNE icon
226
Hamilton Lane
HLNE
$3.63B
-63,619
Closed -$8.54M
IMMX icon
227
Immix Biopharma
IMMX
$607M
-98,040
Closed -$513K
IMNM icon
228
Immunome
IMNM
$2.52B
-102,500
Closed -$2.2M
JEF icon
229
Jefferies Financial Group
JEF
$12.9B
-40,617
Closed -$2.52M
JPM icon
230
JPMorgan Chase
JPM
$939B
-13,050
Closed -$4.2M
MC icon
231
Moelis & Co
MC
$4.98B
-110,660
Closed -$7.61M
MNST icon
232
Monster Beverage
MNST
$91.4B
-115,867
Closed -$8.88M
NTRS icon
233
Northern Trust
NTRS
$22.2B
-65,972
Closed -$9.01M
NVO
234
Novo Nordisk
NVO
$216B
-444,266
Closed -$22.6M
PCTY icon
235
Paylocity
PCTY
$6.71B
-121,383
Closed -$18.5M
PNFP icon
236
Pinnacle Financial Partners Inc
PNFP
$15.5B
-67,341
Closed -$6.43M
RJF icon
237
Raymond James Financial
RJF
$32.5B
-90,741
Closed -$14.6M
RKT icon
238
Rocket Companies
RKT
$36.9B
-436,794
Closed -$8.46M
SBUX icon
239
CALL
Starbucks
SBUX
$118B
-600,000
Closed -$50.5M
SFM icon
240
Sprouts Farmers Market
SFM
$7.04B
-101,644
Closed -$8.1M
SOFI icon
241
SoFi Technologies
SOFI
$21.1B
-34,123
Closed -$893K
SRRK icon
242
Scholar Rock
SRRK
$5.71B
-27,006
Closed -$1.19M
TARA icon
243
Protara Therapeutics
TARA
$226M
-33,857
Closed -$180K
TPG icon
244
TPG
TPG
$6.87B
-374,833
Closed -$23.9M
TXN icon
245
Texas Instruments
TXN
$255B
-47,164
Closed -$8.18M
V icon
246
Visa
V
$677B
-11,489
Closed -$4.03M
WTFC icon
247
Wintrust Financial
WTFC
$10.7B
-64,715
Closed -$9.05M
ULS icon
248
UL Solutions
ULS
$17.2B
-50,823
Closed -$4.01M
CTRI icon
249
Centuri Holdings
CTRI
$2.79B
-177,016
Closed -$4.47M
VIK icon
250
Viking Holdings
VIK
$44.9B
-50,000
Closed -$3.57M

Similar funds

Longaeva Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Longaeva Partners held 269 positions worth $2.7B, up 127% from $1.19B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Longaeva Partners deployed $1.75B of net new capital in Q1 2026, opening 150 new positions and adding to 33 existing holdings. Its largest new stake was Bank of America: 1,555,661 shares worth $75.8M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Annexon, an estimated $14M trimmed.

  • Longaeva Partners's largest Q1 2026 buy was Bank of America: 1,555,661 shares worth $75.8M.
  • Longaeva Partners added most to PNC Financial Services in Q1 2026, an estimated $48M increase.
  • Longaeva Partners's biggest Q1 2026 reduction was Annexon, cutting an estimated $14M.
  • Longaeva Partners fully exited Caris Life Sciences in Q1 2026, selling an estimated $40.7M.
  • Longaeva Partners's ten largest holdings make up 36% of its $2.7B portfolio in Q1 2026.
  • Longaeva Partners opened 150 new positions and closed 65 in Q1 2026.
  • Longaeva Partners's portfolio value rose 127% quarter-over-quarter to $2.7B.

Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.